UK experience in neonatal extracorporeal membrane oxygenation.
Open Access
- 1 July 1992
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 67 (7 Spec No) , 822-825
- https://doi.org/10.1136/adc.67.7_spec_no.822
Abstract
Extracorporeal membrane oxygenation (ECMO) is a life support technique capable of supporting pulmonary, cardiac, or cardiopulmonary function. It has proved most successful in neonatal respiratory failure. We report the initial UK experience with a survival rate of 80% in 15 neonates (gestations 36-41 weeks, birth weights 2690-3990 g) whose condition exceeded American criteria for ECMO treatment for a prolonged period before referral. Ages at referral varied from 11 to 240 hours and the duration of bypass required varied from 30 to 240 hours respectively.Keywords
This publication has 11 references indexed in Scilit:
- Neonatal extracorporeal membrane oxygenation: how not to assess novel technologiesThe Lancet, 1991
- Extracorporeal life support for cardiopulmonary failureCurrent Problems in Surgery, 1990
- Extracorporeal membrane oxygenation.1990
- ECMO and outcome of mechanical ventilation in infants of birthweight over 2 kgThe Lancet, 1990
- Extracorporeal membrane oxygenation.BMJ, 1990
- Morbidity for Survivors of Extracorporeal Membrane Oxygenation: Neurodevelopmental Outcome at 1 Year of AgePediatrics, 1989
- National Experience with Extracorporeal Membrane Oxygenation for Newborn Respiratory FailureAsaio Journal, 1988
- Extracorporeal Membrane Oxygenation (ECMO) in Neonatal Respiratory FailureAnnals of Surgery, 1986
- Extracorporeal Circulation in Neonatal Respiratory Failure: A Prospective Randomized StudyPediatrics, 1985
- Extracorporeal membrane oxygenation for newborn respiratory failure: forty-five cases.1982